
The N-Acetyl Semax Analysis is a targeted laboratory test designed to confirm the identity, determine the amount, and assess the peptide purity of N-Acetyl Semax in lyophilised vials and raw active pharmaceutical ingredient (API) powders.
For lyophilised samples, results are reported in milligrams per vial together with peptide purity. Raw API powders can be evaluated using purity in % (m/m) together with peptide purity.
N-Acetyl Semax is a modified form of Semax, a synthetic heptapeptide studied primarily for its neuroactive and neuroprotective properties.
This form is used primarily as a research compound, and scientific data specifically focused on N-Acetyl Semax remain limited. Research on the parent peptide Semax has examined its effects on the nervous system, cognitive processes, and responses to neurological stress.
Important Notice
- This analysis is specifically intended for N-Acetyl Semax. Before ordering, please make sure that the sample contains this specific form and not another version of Semax.
- The analysis does not automatically screen the sample for standard Semax, N-Acetyl Semax Amidate, other Semax variants, related peptides, degradation products, contaminants, or undeclared substances.
- For lyophilised samples, one whole unopened vial containing lyophilisate is required.
- Raw API powder should be supplied as at least 30 mg in a sealed glass vial to protect the sample from moisture.
- The alternative result format for raw API powders includes both purity in % (m/m) and peptide purity.
The following optional laboratory services are available:
